Arjo initiates a randomized controlled trial for wound care treatment after strong evaluation results

Arjo will today publish the results from a highly successful multi-centre clinical evaluation for the recently launched WoundExpress™. WoundExpress is a ground breaking patented therapy for Venous Leg Ulcers (VLU). Further clinical research studies, including a pivotal randomised controlled trial, are now underway. Arjo aims to establish WoundExpress as the standard of care, given the clear improvements in outcomes for patients and the healthcare system alike. Venous leg ulcers are a rapidly growing problem worldwide with high ongoing treatment costs amounting to over SEK 100 billion, as